dipyridamole has been researched along with Emphysema in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Emphysema: A pathological accumulation of air in tissues or organs.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shih, WJ | 1 |
Li, CY | 1 |
Kiefer, V | 1 |
REESCHUCH, K | 1 |
ULMER, WT | 1 |
2 other studies available for dipyridamole and Emphysema
Article | Year |
---|---|
Significance of the visualization of bone marrow during dipyridamole Tc-99m tetrofosmin myocardial and gated SPECT.
Topics: Aged; Anemia; Bone Marrow; Chest Pain; Dipyridamole; Emphysema; Female; Gated Blood-Pool Imaging; He | 2002 |
[Fuctional analytical studies on the effect of 2,6-bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine on the lung].
Topics: Blood Gas Analysis; Dipyridamole; Emphysema; Humans; Lung; Pyrimidines; Silicosis; Spirometry | 1963 |